Literature DB >> 11859897

Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department.

.   

Abstract

This clinical policy represents an approach that emphasizes key clinical information to determine the severity of CAP. By using this approach, a determination of whether the patient can be treated as an outpatient or inpatient may be made. Recommendations about the utility of ancillary studies and the use of antibiotics are also given. As more of the questions are answered through controlled studies, an evidence-based approach to this problem will become increasingly important in improving the outcome of patients with CAP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11859897     DOI: 10.1067/mem.2001.115880

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  3 in total

1.  Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia.

Authors:  David T Huang; Lisa A Weissfeld; John A Kellum; Donald M Yealy; Lan Kong; Michael Martino; Derek C Angus
Journal:  Ann Emerg Med       Date:  2008-03-17       Impact factor: 5.721

2.  Usefulness of plasma procalcitonin to predict severity in elderly patients with community-acquired pneumonia.

Authors:  Ji Hye Kim; Joo Wan Seo; Jeong Ha Mok; Mi Hyun Kim; Woo Hyun Cho; Kwangha Lee; Ki Uk Kim; Doosoo Jeon; Hye-Kyung Park; Yun Seong Kim; Hyung Hoi Kim; Min Ki Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-05-31

3.  Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Authors:  Lionel A Mandell; John G Bartlett; Scott F Dowell; Thomas M File; Daniel M Musher; Cynthia Whitney
Journal:  Clin Infect Dis       Date:  2003-11-03       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.